I have not merely suggested elsewhere, but actively lectured and campaigned against the excessive use, or abuse, of immunization. This runs counter to the orthodox view where the clanging symbols are in favor of massive promotion of immunization programs.

I am frankly dismayed at the large number of well qualified and highly educated medical practitioners and researchers (no, not the ordinary local doctors and the like, they are pretty clueless and just do and parrot what they are told) who strongly advocate the use of immunization en masse.

Can you say monkey virus? How quickly people forget when authorities want them to. Tens of thousands of people were knowingly immunized with contaminated materials decades ago and the fallout will largely be covered up.

Quite apart from the sledge hammer treatment of the immune system that immunization really is, and all the unknown damage it causes, there is the ever present risk that the materials used are unsafe in other ways.

The case referred to above is a scandalous example from the past. Here is a good example of my point from today, courtesy of the FDA. Read the following very carefully and then do some serious thinking. If you are a proponent of immunization it may be a refreshing change.

FDA and CDC notified consumers and health care providers of five reports of Guillain Barre Syndrome following administration of Meningococcal Conjugate Vaccine A, C, Y, and W135 (trade name Menactra), manufactured by Sanofi Pasteur. It is not known yet whether these cases were caused by the vaccine or are coincidental. FDA and CDC are sharing this information with the public now and actively investigating the situation because of its potentially serious nature. Guillain Barre Syndrome (GBS) is a serious neurological disorder that can occur, often in healthy individuals, either spontaneously or after certain infections. GBS typically causes increasing weakness in the legs and arms that can be severe and require hospitalization. Because of the potentially serious nature of this matter, FDA and CDC are asking any persons with knowledge of any possible cases of GBS occurring after Menactra to report them to the Vaccine Adverse Event Reporting System <https://secure.vaers.org/VaersDataEntryintro.htm>  (VAERS) to help the agencies further evaluate the matter.

Please don’t give me the ridiculous lines from low level utilitarian ethics about the greatest good for the greatest number. That ethics of convenience simply doesn’t wash with me. Nor, I suggest, will it be much comfort to those who contract GBS.

Optimize your nutrition, pursue a health promoting lifestyle and when necessary take steps to boost your immune performance with herbal, nutritional and even psychosocial means. But for your health’s sake, don’t participate in mass immunization without a very clear understanding of what you are doing. Sometimes the risks of immunization are outweighed by the risks of not immunizing, but the real truth is, that is very rare indeed.

Share with friends:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • LinkedIn
  • MySpace
  • StumbleUpon
  • Twitthis
  • Yahoo! Bookmarks

3 Comments to “Is Immunization Worth The Risks?”

  1. Health Gazette says:

    An update relating to the period from October 2005 to February 2006 has been posted by the CDC. It is an interesting report that artfully treads the line between scientific honesty and transparent reporting on the one side and a clear agenda to find no reasons suggesting that the vaccine should be withdrawn. However, it is clear that a strong bias towards the latter exists.

    The bias is understandable, though regrettable. The CDC is motivated by a need to control meningococcal disease and would doubtless feel that withdrawal of the vaccine would leave the population without defences. This is a scary prospect for the CDC and given its love of vaccination I should think it would take a quite demonstrable level of harm before withdrawal would be seriously contemplated.

    This is all well and good if you happen to be a health planner safely ensconced in a bureaucracy. It is not good however for the people who do have adverse ractions to the vaccines or for their loved ones.

    Seeing distressed family members sitting in an intensive care unit by a ventillated patient whose GBS has rendered them unable to breathe and realizing that this situation has been caused by a vaccination “mishap” is a very different experience. It is interesting to note that while CDC ’scientists’ look at the big picture and explain such events away as mere statistical happenstance, clinicians have no such difficulty in recognizing a definite link between vaccination and disease. Of course, not many have the courage to say so publicly.

    Peter
    ________________
    Dr Peter Tylee
    Editor

  2. Health Gazette says:

    Here is an update on this story. After a ponderous silence for months during which most watchers have lost interest, the FDA and CDC have slipped the following notification quietly onto the obligatory public places. Their agend appears to be unfolding as per normal.

    FDA and CDC updated an October 2005 alert to consumers and health care providers regarding reports of Guillain Barre Syndrome (GBS) following administration of Meningococcal Conjugate Vaccine A, C, Y, and W135, manufactured by Sanofi Pasteur. To date a total of 15 confirmed cases of GBS among individuals 11-19 years of age occurring within six weeks of vaccination with Menactra have been reported to the Vaccine Adverse Event Reporting System (VAERS). Two additional cases have been confirmed in persons 20 years of age and older. All individuals are reported to be recovering or have recovered.

    While the cases reported suggest a small increased risk of GBS following immunization with Menactra, the limitations in VAERS, and the uncertainty regarding background incidence rates for GBS require that these findings be viewed with caution. At this time, CDC and FDA cannot determine with certainty whether Menactra does increase the risk of GBS in persons who receive the vaccine and, if so, to what degree. At the present time, there are no changes in recommendations for vaccination and individuals should continue to follow their doctors’ recommendations. FDA asks any persons with knowledge of possible cases of GBS occurring after receiving Menactra to report them to VAERS at http://www.vaers.hhs.gov or by phone at 1-800-822-7967.

    Read the complete MedWatch 2006 Safety summary, including links to the FDA and CDC update documents, at:

    http://www.fda.gov/medwatch/sa.....m#Menactra

    Seventeen confirmed cases of GBS following vaccination may seem to be a small number to health bureaucrats (including the clinicians who have retreated to become pen pushers). It is a very large number if you happen to be one of the 17 or part of their family or one of their friends.

    The biased and somewhat defensive tone of this statement by the CDC and FDA reminds me of similary documents when the claims were that “there is no conclusive scientific proof that smoking causes lung cancer” … yeah, right.

    Peter
    ________________
    Dr Peter Tylee
    Editor

Leave a Reply

You must be logged in to post a comment.